Skip to main content

Probiotics as part of the management of irritable bowel syndrome (IBS): considerations for pharmacy settings

Irritable Bowel Syndrome (IBS) in Pharmacy Settings: How Does it Present and First Line Management

0.5 CPD learning hours

In this short symposium recorded for the 2024 pharmacy show, Dr Choudhary provides an overview of irritable bowel syndrome (IBS), with a focus upon the role of specific strains of probiotics as part of the management of symptoms, before reflecting on her own clinical practice to share top tips for pharmacists to consider when discussing and recommending probiotic products to individuals.

Learning Objectives:

  • Understand IBS definition as a disorder of gut-brain interaction (DGBI) and diagnostic criteria 
  • Get topline summary of clinical management guidelines for IBS (dietary and lifestyle changes, pharmacological and psychotherapy approaches)
  • Overview and summary of potential role of probiotics as part of holistic management approach to IBS 
  • Summary of research evidence (focus on Bifidobacterium longum 35624® and 1714® - individual and in combination) from clinical trials and real-world evidence studies.
  • Reflect on real-life clinical experiences with IBS patients, including common misconceptions and frequently asked questions.

 

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.